FSTX
NASDAQF-star Therapeutics Inc.
Latest news
25 items- PRAvacta Announces the Appointment of Darlene Deptula-Hicks as Non-Executive Director of the Board of DirectorsAvacta Group plc Avacta Announces the Appointment of Darlene Deptula-Hicks as Non-Executive Director of the Board of Directors London, England; July 8, 2024; Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted cancer treatments and powerful diagnostics, today announced the appointment of Darlene Deptula-Hicks, MBA as a Non-Executive Director of the Company's Board of Directors, effective 26 June 2024. Ms. Deptula-Hicks is a highly accomplished financial executive with decades of experience working with and advising private and public life sciences companies. Shaun Chilton, Chairman of the Board of Avacta, commented: "Avacta is at a pivotal time in its e
- PRLevicept Appoints Eliot Forster as CEOLeadership Team Strengthened as Clinical Development of LEVI-04 a Novel Neurotrophin Modulator for Osteoarthritis and Chronic Pain Advances SANDWICH, United Kingdom, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Levicept Ltd, a biotechnology company focused on the development of LEVI-04, a first-in-class treatment for chronic pain indications, today announces the appointment of Eliot Forster as CEO. Founder and inventor of LEVI-04, Simon Westbrook, is to take the role of CSO. Eliot brings more than thirty years of experience in the biotech and pharmaceutical sectors, with considerable experience in deal making and finance. His appointment strengthens the Levicept leadership team as the company matur
- SECSEC Form 15-12G filed by F-star Therapeutics Inc.15-12G - F-star Therapeutics, Inc. (0001566373) (Filer)
- 13D/GSEC Form SC 13G filed by F-star Therapeutics Inc.SC 13G - F-star Therapeutics, Inc. (0001566373) (Subject)
- SECSEC Form EFFECT filed by F-star Therapeutics Inc.EFFECT - F-star Therapeutics, Inc. (0001566373) (Filer)
- SECSEC Form EFFECT filed by F-star Therapeutics Inc.EFFECT - F-star Therapeutics, Inc. (0001566373) (Filer)
- SECSEC Form EFFECT filed by F-star Therapeutics Inc.EFFECT - F-star Therapeutics, Inc. (0001566373) (Filer)
- SECSEC Form EFFECT filed by F-star Therapeutics Inc.EFFECT - F-star Therapeutics, Inc. (0001566373) (Filer)
- SECSEC Form EFFECT filed by F-star Therapeutics Inc.EFFECT - F-star Therapeutics, Inc. (0001566373) (Filer)
- INSIDERSEC Form 4: Kayitalire Louis returned $178,135 worth of shares to the company (25,019 units at $7.12), closing all direct ownership in the company to satisfy tax liability4 - F-star Therapeutics, Inc. (0001566373) (Issuer)
- INSIDERSEC Form 4: Forster Eliot returned $526,588 worth of shares to the company (73,959 units at $7.12), closing all direct ownership in the company (for withholding tax)4 - F-star Therapeutics, Inc. (0001566373) (Issuer)
- INSIDERSEC Form 4 filed by Klein Pamela M.4 - F-star Therapeutics, Inc. (0001566373) (Issuer)
- INSIDERSEC Form 4: Deptula-Hicks Darlene M returned $181,838 worth of shares to the company (25,539 units at $7.12), closing all direct ownership in the company to cover withholding tax4 - F-star Therapeutics, Inc. (0001566373) (Issuer)
- INSIDERSEC Form 4: Brady Todd C closing all direct ownership in the company (withholding tax)4 - F-star Therapeutics, Inc. (0001566373) (Issuer)
- INSIDERSEC Form 4: Brewis Neil returned $66,750 worth of shares to the company (9,375 units at $7.12), closing all direct ownership in the company (for withholding tax)4 - F-star Therapeutics, Inc. (0001566373) (Issuer)
- INSIDERSEC Form 4: Race Geoffrey closing all direct ownership in the company to cover taxes4 - F-star Therapeutics, Inc. (0001566373) (Issuer)
- INSIDERSEC Form 4: Benz Edward Jr returned $31,221 worth of shares to the company (4,385 units at $7.12), closing all direct ownership in the company (tax withholding)4 - F-star Therapeutics, Inc. (0001566373) (Issuer)
- INSIDERSEC Form 4: Bermingham Nessan returned $45,055 worth of shares to the company (6,328 units at $7.12), closing all direct ownership in the company (for tax liability)4 - F-star Therapeutics, Inc. (0001566373) (Issuer)
- INSIDERSEC Form 4: Arkowitz David closing all direct ownership in the company (for withholding tax)4 - F-star Therapeutics, Inc. (0001566373) (Issuer)
- SECSEC Form S-8 POS filed by F-star Therapeutics Inc.S-8 POS - F-star Therapeutics, Inc. (0001566373) (Filer)
- SECSEC Form S-8 POS filed by F-star Therapeutics Inc.S-8 POS - F-star Therapeutics, Inc. (0001566373) (Filer)
- SECSEC Form S-8 POS filed by F-star Therapeutics Inc.S-8 POS - F-star Therapeutics, Inc. (0001566373) (Filer)
- SECSEC Form S-8 POS filed by F-star Therapeutics Inc.S-8 POS - F-star Therapeutics, Inc. (0001566373) (Filer)
- SECSEC Form S-8 POS filed by F-star Therapeutics Inc.S-8 POS - F-star Therapeutics, Inc. (0001566373) (Filer)
- SECSEC Form S-8 POS filed by F-star Therapeutics Inc.S-8 POS - F-star Therapeutics, Inc. (0001566373) (Filer)
FSTX FAQ
7 questionsWhat does F-star Therapeutics Inc. do?
F-star Therapeutics, Inc., a clinical-stage biopharmaceutical company develops tetravalent bispecific antibodies for cancer therapy. Its medicines are used in immuno-oncology treatments. The company's principal product candidate is FS118, is currently being evaluated in a proof-of-concept Phase 2 trial in PD-1/PD-L1 acquired resistance head and neck cancer patients. It is also developing first-in-human clinical study of FS222, a bispecific antibody targeting CD137 (4-1BB) and PD-L1. The company was incorporated in 2002 and is headquartered in Cambridge, the United Kingdom.Where does FSTX stock trade?
F-star Therapeutics Inc. (FSTX) is listed on NASDAQ.What sector and industry is FSTX in?
F-star Therapeutics Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.When did F-star Therapeutics Inc. go public?
F-star Therapeutics Inc. (FSTX) completed its IPO in 2016.What are analysts saying about FSTX?
F-star Therapeutics Inc. has had 4 recent analyst actions on file. The most recent action was from H.C. Wainwright: Neutral with a $700.00 price target on 2022-07-15.What companies are similar to FSTX?
Notable peers in the same industry include LLY (Eli Lilly and Company), JNJ (Johnson & Johnson), AZN (AstraZeneca PLC), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.). Compare FSTX side-by-side with any of them on Quantisnow.How can I track FSTX on Quantisnow?
Quantisnow aggregates F-star Therapeutics Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow FSTX to receive live email and push alerts on every new disclosure.